Mark Cherney is the Founder and Executive Chairman of both US Urology Partners and Prologics. This past year Mark transitioned from the CEO role into the Executive Chair role and in this brief discussion he introduces some of the headwinds ahead for both Private Equity & the medical practices that have been part of PE roll-ups.
NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port...
RiskLD is a physician-led startup out of Cleveland focused on improving maternity outcomes.
In this episode, Ryan Khanna, MD, MBA co-hosts a discussion with Robert Eastlack who runs a premier surgical spine practice in San Diego, CA...
